MBP and glioblastoma: In both established and patient-derived GBM cells, we observed an increase in expression of GFAP and, to a lesser extent, the oligodendrocytic markers MBP or CNPase, in response to ectopic NFIB expression in mesenchymal and classical GBM lines (Figure 4A).